Smoking Cessation for Cervical Cancer Survivors

Summary

The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.

Conditions

• Cervical Cancer
• Tobacco Use
• Smoking Cessation

Interventions

BEHAVIORAL

Self-Help Materials

Participants receive free self-help materials mailed at baseline, 6, and 12 months. and a referral to the Oklahoma Quitline.

DRUG

Nicotine Patch

Participants receive a 12-week supply of nicotine patch. Nicotine patch regime based on participant's self-reported smoking rate. Participants who smoke \>10 cigarettes/day receive 8 weeks of 21 mg, 2 week of 14 mg, and 2 week of 7 mg patches. Those who smoke \<10 cigarettes/day receive 8 weeks of 14 mg and 4 weeks of 7 mg patches.

BEHAVIORAL

REDCap

REDCap will be used to collect all questionnaires data over the phone. Questionnaires done at baseline to randomize, then at 3, 6, 12, and 18 months.

PROCEDURE

Saliva Test

Saliva test performed at 3, 6, 12, and 18 months.

BEHAVIORAL

Telephone Counseling Sessions

6 telephone counseling sessions performed over 12 months. Sessions performed at baseline, 3, 6, 12, and 18 months. Sessions digitally recorded.

DRUG

Nicotine lozenge

Participants receive a 12-week supply of nicotine lozenges. All participants receive 12 weeks of 2mg lozenges.

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• H. Lee Moffitt Cancer Center and Research Institute

  lead OTHER

Principal Investigators

• Jennifer Vidrine, PHD · H. Lee Moffitt Cancer Center and Research Institute

Study Design

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-01-31

Primary Completion

2021-08-31

Completion

2021-08-31

Countries

• United States

Study Locations